Medical Cyclotron Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Cyclotron Market 

5.1. COVID-19 Landscape: Medical Cyclotron Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Cyclotron Market, By Product Type

8.1. Medical Cyclotron Market Revenue and Volume Forecast, by Product Type

8.1.1. Fixed energy cyclotron

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Variable energy cyclotron

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Low-energy cyclotron

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Medium-energy cyclotron

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. High-energy cyclotron

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Medical Cyclotron Market, By Radioisotope Produced

9.1. Medical Cyclotron Market Revenue and Volume Forecast, by Radioisotope Produced

9.1.1. Fluorine-18

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Carbon-11

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Nitrogen-13

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Oxygen-15

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Gallium-68

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Copper-64

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Iodine-123

9.1.7.1. Market Revenue and Volume Forecast

9.1.8. Thallium-201

9.1.8.1. Market Revenue and Volume Forecast

9.1.9. Others

9.1.9.1. Market Revenue and Volume Forecast  

Chapter 10. Global Medical Cyclotron Market, By Application

10.1. Medical Cyclotron Market Revenue and Volume Forecast, by Application

10.1.1. Diagnostic imaging

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Therapeutic isotope production

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Research applications

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Medical Cyclotron Market, By End User

11.1. Medical Cyclotron Market Revenue and Volume Forecast, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic imaging centers

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Academic and research institutes

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Radiopharmaceutical companies

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Medical Cyclotron Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Radioisotope Produced

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. GE HealthCare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Siemens Healthineers

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Ion Beam Applications SA (IBA)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. Sumitomo Heavy Industries, Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Advanced Cyclotron Systems Inc. (ACSI)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Best Cyclotron Systems (TeamBest Global)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. The Japan Steel Works, Ltd. (JSW)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Shinva Medical Instrument Co., Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. IONETIX Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. PMB-ALCEN

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms